GI
VRTX icon

GAMMA Investing’s Vertex Pharmaceuticals VRTX Stock Holding History

GAMMA Investing’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.44M Buy
6,918
+326
+5% +$144K 0.13% 128
2026
Q1 		$2.94M Buy
6,592
+878
+15% +$409K 0.14% 120
2025
Q4 		$2.59M Buy
5,714
+1,082
+23% +$466K 0.13% 124
2025
Q3 		$1.81M Sell
4,632
-80
-2% -$33.4K 0.1% 171
2025
Q2 		$2.1M Sell
4,712
-290
-6% -$134K 0.13% 127
2025
Q1 		$2.43M Buy
5,002
+1,005
+25% +$468K 0.18% 93
2024
Q4 		$1.61M Buy
3,997
+87
+2% +$40.3K 0.14% 128
2024
Q3 		$1.82M Buy
3,910
+909
+30% +$437K 0.18% 105
2024
Q2 		$1.41M Buy
3,001
+833
+38% +$362K 0.19% 92
2024
Q1 		$906K Buy
2,168
+163
+8% +$68.9K 0.18% 93
2023
Q4 		$869K Buy
+2,005
New +$741K 0.24% 67

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return

GAMMA Investing's VRTX Position: Q2 2026 in Review

GAMMA Investing increased its Vertex Pharmaceuticals (VRTX) stake by 4.9% in Q2 2026, buying an estimated $144K and bringing the position to 6,918 shares worth $3.44M. The position accounts for 0.13% of the portfolio, ranked #128.

GAMMA Investing first reported a position in VRTX in Q4 2023 and has held it in 11 quarters since. 308 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • GAMMA Investing held 6,918 shares of Vertex Pharmaceuticals worth $3.44M as of Q2 2026.
  • GAMMA Investing bought 326 Vertex Pharmaceuticals shares in Q2 2026, an estimated $144K.
  • Vertex Pharmaceuticals made up 0.13% of GAMMA Investing's portfolio in Q2 2026, its #128 holding.
  • GAMMA Investing first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 308 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.